SCOTUS Places Stay on ‘Criminal Enterprise’ Conspiracy
The FDA loosened restrictions on mifepristone distribution during the Obama and Biden administrations despite mounting evidence that chemical abortions are sending increasing numbers of women to emergency rooms. Yet instead of urgently completing the promised safety review, the federal government appears to be slow-walking accountability. In a recent dissenting opinion whereby the Court’s majority permitted